Effects of continuous infusion of endothelin-1 in pregnant sheep

Hypertension

Volumn 30, Issue 6, 1997, Pages 1585-1590

  Greenberg, Suzanne G ^a   Baker, R Scott ^a   Yang, DaSeng ^a   Clark, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Endothelin 1; Kidney; Preeclampsia; Proteinuria; Sheep

Indexed keywords

ENDOTHELIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCULATION; CELL DAMAGE; FEMALE; HEMATOCRIT; HYPOTHESIS; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MEAN ARTERIAL PRESSURE; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; SHEEP; UTERUS BLOOD FLOW;

EID: 0030659830     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1585     Document Type: Article

References (41)

1. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol. 1985;248:C550-C556.
2. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
3. Remuzzi G, Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet. 1993;342:589-593.
4. Luscher TF, Bock HA, Yang Z, Diederich D. Endothelium-derived relaxing and contracting factors: perspectives in nephrology. Kidney Int. 1991;39:575-590.
5. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200-1204.
6. Lerman A, Kubo S, Tschumperlin LK, Burnett JC. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol. 1992;20:849-853.
7. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and hepatorenal syndrome. N Engl Med. 1992;327:1774-1778.
8. Tomita K, Ujiie K, Nakanashi T, Tomura S, Matsuda O, Ando K, Schichiri M, Hirata Y, Marumo F. Plasma endothelin levels in patients with acute renal failure. N Engl J Med. 1989;321:1127.
9. Warrens AN, Cassidy MJD, Takahashi K, Ghatei MA, Bloom SR. Endothelin in renal failure. Nephrol Dial Transplant. 1990;5: 418-422.
10. Dekker GA, Kraayenbrink AA, Zeeman GG, van Kamp GJ. Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe preeclampsia. Eur J Obstet Gynecol Reprod Biol. 1991;40:215-220.
11. Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol. 1993;169:160-165.
12. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol. 1991;165:724-727.
13. Sudo N, Kamoi K, Ishibashi M, Yamaji T. Plasma endothelin-1 and big endothelin-1 levels in women with preeclampsia. Acta Endocrinol. 1993;129:114-120.
14. Taylor RN, Varma M, Teng NNH, and Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 1990;71: 1675-1677.
15. Ferris TF. Hypertension in pregnancy. Kidney. 1992;23:1-5.
16. Kincaid-Smith PS, Fairley KF. The Kidney and Hypertension in Pregnancy. New York, NY: Churchill Livingstone; 1993.
17. Friedman SA, Taylor RN, Robert JM. Pathophysiology of preeclampsia. Hypertension in Pregnancy. 1991;18:661-682.
18. Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol. 1988;159:908-914.
19. Zeeman GG, Dekker GA, van Geijn HP, Kraayenbrink AA. Endothelial function in normal and preeclamptic pregnancy: a hypothesis. Eur J Obstet Gynecol Reprod Biol. 1992;43:113-122.
20. Miller WL, Redfield MM, Burnett JC. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest. 1989;83:317-320.
21. Remuzzi G, Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet 1993;342:589-593.
22. Yang D, Clark KE. Effect of endothelin-1 on the uterine vasculature of the pregnant and estrogen treated nonpregnant sheep. Am J Obstet Gynecol. 1992;167:1642-1650.
23. Bodelsson G, Sjoberg N-O, Stjernquist M. Contractile effect of endothelin in the human uterine artery and autoradiographic localization of its binding sites. Am J Obstet Gynecol. 1992; 167:745-750.
24. Vemulapalli S, Chiu PJS, Chintala M, Bernardino V. Attenuation of ischemic acute renal failure by phosphoramidon in rats. Pharmacology. 1993;47:188-193.
25. Cornet S, Braillon A, Guilmard C, Chabrier P-E, Pirotzky E, Braquet P. Involvement of endothelin in renal processes. Hypertension. 1990;15:724-728.
26. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int. 1993;43:354-358.
27. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int. 1993;44:440-444.
28. Fischereder M, Trick W, Nath KA. Therapeutic strategies in the prevention of acute renal failure. Semin Nephrol. 1994;14:41-52.
29. Perico N, Remuzzi G. The possible role of endothelin in the process of progressive renal deterioration in experimental and human glomerulopathies. Semin Nephrol. 1993;13:137-143.
30. Kovilam O, Greenberg SG, Baker RS, Clark KE. Pregnancy is associated with an increased metabolism of endothelin-1. Society for Gynecological Investigation, 1997. Abstract.
31. Clark KE, Mack CE. Fetal umbilical vascular response to endothelial derived contracting factor-endothelin. Society for Gynecological Investigation; San Antonio, Tex;1991. Abstract 113.
32. Myatt L, Langdon G, Brewer AS, Brockman DE. Endothelin-1-induced vasoconstriction is not mediated by thromboxane release and action in the human fetal-placental circulation. Am J Obstet Gynecol. 1991;165:1717-1722.
33. DeBoer K, Lecander I, ten Cate JW, Borm JJJ, Treffers PE. Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol. 1988;158:518-522.
34. Friedman SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM. Biochemical corroboration of endothelial involvement in sever preeclampsia. Am J Obstet Gynecol. 1995;172:202-203.
35. Campbell WB, and Henrich WL. Endothelial factors in the regulation of renin release. Kidney Int. 1990;38:612-617.
36. de Jong CLD, Dekker GA, Sibai BH. The renin-aldosterone system in preeclampsia. Clin Perinatol. 1991;18:683-711.
37. Lopez-Farre A, Gomez-Garre D, Bernabeu F, Montanes I, Millas I, Lopez-Novoa JM. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int. 1991;39: 624-630.
38. Montero A, Rodriguez-Barbero A, Lopez-Novoa JM. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. Eur J Pharmacol. 1993;243:235-240.
39. Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br J Pharmacol. 1991;104: 797-804.
40. Brown MA, Whitworth JA. The kidney in hypertensive pregnancies: victim and villain. Am J Kidney Dis. 1992;20:427-442.
41. Moise KJJ, Cotton DB. COP: its uses during pregnancy. Contemp Obstet Gynecol. 1985;26:133-138